Clearside Biomedical Inc at Needham Healthcare Conference (Virtual) Transcript
Good afternoon and welcome to Needham's 21st annual healthcare conference. I'm Serge Belanger, one of the healthcare analysts at Needham. We're happy to have the Clearside Biomedical team with us this afternoon. So from the company, we have Charlie Deignan, the CFO; as well as Tom Ciulla, who is the Chief Medical Officer of the company.
So I'll hand it over to Charlie and Tom to give us an overview of Clearside, and then I think we'll have time for some Q&A at the end. For those listening online, I think you can submit questions via the portal. We'll be looking at those when we move over towards the Q&A portion.
So, gentlemen, the floor is yours.
Well, thanks for having us, Serge. As a retina specialist, I'm very excited to be part of a potential paradigm shift in the way we deliver retinal therapeutics. Next slide, please.
I'd like to remind you that we may make forward-looking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
